Hikma Pharmaceutical | HIK - Stock


Hikma Pharmaceutical reported $1.08B in Stock for its fiscal semester ending in June of 2025.





Stock Change Date
Almirall EUR 178.13M 1.54M Dec/2025
argenx SE USD 473.53M 132.91M Dec/2025
AstraZeneca USD 6.57B 13M Mar/2026
Autolus Therapeutics Ltd USD 33.23M 24K Mar/2026
Bayer EUR 12.34B 3M Dec/2025
Fresenius EUR 2.61B 19M Dec/2025
Genmab DKK 13M 1000K Jun/2025
GlaxoSmithKline GBP 6.16B 233M Mar/2026
GRIFOLS EUR 3.35B 213.23M Jun/2025
Hikma Pharmaceutical USD 1.08B 96M Jun/2025
Lakefront Biotherapeutics EUR 17.69M 4.8M Mar/2026
Lonza CHF 1.68B 163M Dec/2025
Merck EUR 4.56B 52M Dec/2025
Orion EUR 456.3M 12.6M Dec/2025
Recordati EUR 539.8M 34.61M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025
UCB EUR 1.31B 173M Dec/2024